Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Synthesis and preliminary in vitro evaluation of antimycobacterial activity of new pyrrolo[1,2-a] quinoxaline-carboxylic acid hydrazide derivatives.
|
J Enzyme Inhib Med Chem
|
2004
|
0.95
|
2
|
Synthesis of a novel class of non-peptide NK-2 receptor ligand, derived from 1-phenyl-3-pyrrol-1-ylindan-2-carboxamides.
|
Bioorg Med Chem
|
2002
|
0.92
|
3
|
Synergistic effect of acetylcholinesterase inhibition (donepezil) and 5-HT(4) receptor activation (RS67333) on object recognition in mice.
|
Behav Brain Res
|
2012
|
0.84
|
4
|
MR22388, a novel anti-cancer agent with a strong FLT-3 ITD kinase affinity.
|
Cancer Lett
|
2012
|
0.80
|
5
|
Synthesis of new 4-[2-(alkylamino) ethylthio]pyrrolo[1,2-a]quinoxaline and 5-[2-(alkylamino) ethylthio]pyrrolo[1,2-a]thieno[3,2-e]pyrazine derivatives, as potential bacterial multidrug resistance pump inhibitors.
|
J Enzyme Inhib Med Chem
|
2007
|
0.80
|
6
|
Hydrogenative desulphurization of thienopyrrolizinones: an easy and selective access to (Z)-phenethylidenepyrrolizinones with in vitro cytotoxic activity.
|
Eur J Med Chem
|
2009
|
0.78
|
7
|
Tripentones: a promising series of potent anti-cancer agents.
|
Anticancer Agents Med Chem
|
2009
|
0.77
|
8
|
Synthesis and biological evaluation of thienopyrrolizines, a new family of CDK/GSK-3 inhibitors.
|
J Enzyme Inhib Med Chem
|
2004
|
0.77
|
9
|
Synthesis, antimalarial activity, and molecular modeling of new pyrrolo[1,2-a]quinoxalines, bispyrrolo[1,2-a]quinoxalines, bispyrido[3,2-e]pyrrolo[1,2-a]pyrazines, and bispyrrolo[1,2-a]thieno[3,2-e]pyrazines.
|
J Med Chem
|
2004
|
0.76
|
10
|
Virtual screening discovery of new acetylcholinesterase inhibitors issued from CERMN chemical library.
|
J Chem Inf Model
|
2010
|
0.76
|
11
|
A first cyclopenta[c]thiophene dimer as a new bivalent potent cytotoxic derivative.
|
J Enzyme Inhib Med Chem
|
2002
|
0.75
|
12
|
Synthesis of novel 7-oxo and 7-hydroxy trifluoroallocolchicinoids with cytotoxic effect.
|
Bioorg Med Chem
|
2012
|
0.75
|
13
|
Synthesis and preliminary in vivo evaluation of new 2-Aryl-6-methyl-1,2-dihydro-1H-pyridin-4-ones and 2-Aryl-6-methylpiperidin-4-ols, as potential anti-amnesiant agents.
|
J Enzyme Inhib Med Chem
|
2005
|
0.75
|
14
|
Synthesis and biological evaluation of new donepezil-like Thiaindanones as AChE inhibitors.
|
J Enzyme Inhib Med Chem
|
2008
|
0.75
|
15
|
N-substituted piperazinopyridylsteroid derivatives as abiraterone analogues inhibit growth and induce pro-apoptosis in human hormone-independent prostate cancer cell lines.
|
Chem Biol Drug Des
|
2013
|
0.75
|
16
|
Synthesis, reactivity and biological evaluation of novel halogenated tripentones.
|
Bioorg Med Chem
|
2009
|
0.75
|
17
|
Synthesis and initial results for MAO-B inhibition by new N-propargyl-3-pyrrol-1-ylindanamine derivatives, analogues of rasagiline.
|
J Enzyme Inhib Med Chem
|
2003
|
0.75
|
18
|
Synthesis of new bisaryl cyclopentathiophene and thienocyclopentoxazolidine derivatives as potential cytotoxic agents.
|
J Enzyme Inhib Med Chem
|
2007
|
0.75
|
19
|
Intramolecular cyclisation of β-aryl-β-amino acids in the design of novel heterocyclic systems with therapeutic interest: an unfailing source of diversity.
|
Curr Med Chem
|
2010
|
0.75
|
20
|
Synthesis of new dipyrrolo- and furopyrrolopyrazinones related to tripentones and their biological evaluation as potential kinases (CDKs1-5, GSK-3) inhibitors.
|
Eur J Med Chem
|
2008
|
0.75
|
21
|
[Study of in vitro cytotoxic activity of cyclopentanones derivatives].
|
Tunis Med
|
2004
|
0.75
|
22
|
Synthesis and biological evaluation as AChE inhibitors of new indanones and thiaindanones related to donepezil.
|
Eur J Med Chem
|
2005
|
0.75
|